Fresenius Medical Care Files 6-K with Press Release
Ticker: FMCQF · Form: 6-K · Filed: May 16, 2024 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
Related Tickers: FMS
TL;DR
FMS just dropped a 6-K with a press release on May 16th - check Exhibit 99.1 for deets.
AI Summary
Fresenius Medical Care AG filed a Form 6-K on May 16, 2024, to report a press release issued on the same date. The press release, filed as Exhibit 99.1, contains information relevant to the company's operations and financial status. The filing itself does not contain specific financial figures or operational updates beyond referencing the attached press release.
Why It Matters
This filing indicates Fresenius Medical Care is providing updated information to the market via a press release, which could contain material news affecting the company's stock.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to submit an attached press release, without introducing new material risks within the filing itself.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- May 16, 2024 (date) — Date of press release and filing
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose of this 6-K filing is to furnish a press release issued by Fresenius Medical Care AG on May 16, 2024, as Exhibit 99.1.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 16, 2024.
What is the Commission file number for Fresenius Medical Care AG?
The Commission file number for Fresenius Medical Care AG is 001-32749.
Where is Fresenius Medical Care AG's principal executive office located?
Fresenius Medical Care AG's principal executive office is located at Else-Kröner Strasse 1, 61346 Bad Homburg, Germany.
What exhibit is being furnished with this Report?
Exhibit 99.1, a Press Release issued on May 16, 2024, is being furnished with this Report.
Filing Stats: 176 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-05-16 10:35:26
Filing Documents
- tm2414711d1_6k.htm (6-K) — 10KB
- tm2414711d1_ex99-1.htm (EX-99.1) — 13KB
- tm2414711d1_ex99-1img001.jpg (GRAPHIC) — 9KB
- 0001104659-24-062348.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: May 16, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board